Inhibitory Effects of 4-Guanidinobutyric Acid Against Gastric Lesions

Overview

Journal Biomol Ther (Seoul)

Specialty Pharmacology

Date 2013 Oct 12

PMID 24116302

Citations 6

Authors

In Young Hwang

Choon Sik Jeong

Affiliations

Soon will be listed here.

Abstract

This study examined the inhibitory effects of 4-guanidinobutyric acid (4GBA), an alkaloid, against gastric lesions by assessing the inhibition of Helicobacter pylori (H. pylori) and gastric cancer cells. Acute and chronic gastritis were also observed using HCl/ethanol (EtOH) and indomethacin-induced gastric lesion models, respectively. 4GBA inhibited the growth of H. pylori in a dose dependent manner, and showed acid-neutralizing capacity. In the pylorus ligated rats, 4GBA decreased the volume of gastric secretion and gastric acid output slightly, and increased the pH. 4GBA at a dose of 100 mg/kg reduced the size of HCl/EtOH-induced gastric lesions (70.8%) and indomethacin-induced gastric lesions (38.8%). The antigastritic action of 4GBA might be associated with the acid-neutralizing capacity, anti-H. pylori action, and decreased volume of gastric secretion. These results suggest that 4GBA might be useful in the treatment and/or protection of gastritis.

Citing Articles

Carrot-Derived Rhamnogalacturonan-I Consistently Increases the Microbial Production of Health-Promoting Indole-3-Propionic Acid Ex Vivo.

Mercenier A, Vu L, Poppe J, Albers R, McKay S, Van den Abbeele P Metabolites. 2024; 14(12).

PMID: 39728503 PMC: 11678764. DOI: 10.3390/metabo14120722.

Ethnobotany and phytochemistry of plants used to treat musculoskeletal disorders among Skaw Karen, Thailand.

Kantasrila R, Pandith H, Balslev H, Wangpakapattanawong P, Panyadee P, Inta A Pharm Biol. 2023; 62(1):62-104.

PMID: 38131672 PMC: 10763916. DOI: 10.1080/13880209.2023.2292261.

inhibitory effects on free radicals, pigmentation, and skin cancer cell proliferation from hybrid extract: A new plant source of active compounds.

Swainson N, Pengoan T, Khonsap R, Meksangsee P, Hagn G, Gerner C Heliyon. 2023; 9(9):e20197.

PMID: 37809523 PMC: 10559953. DOI: 10.1016/j.heliyon.2023.e20197.

Study on the Mechanism of Qing-Fei-Shen-Shi Decoction on Asthma Based on Integrated 16S rRNA Sequencing and Untargeted Metabolomics.

Hu H, Zhao G, Wang K, Han P, Ye H, Wang F Evid Based Complement Alternat Med. 2023; 2023:1456844.

PMID: 36846048 PMC: 9946754. DOI: 10.1155/2023/1456844.

Effect of traditional chinese medicine (TCM) and its fermentation using Lactobacillus plantarum on ceftriaxone sodium-induced dysbacteriotic diarrhea in mice.

Guo X, Yan Z, Wang J, Fan X, Kang J, Niu R Chin Med. 2022; 17(1):20.

PMID: 35139871 PMC: 8827261. DOI: 10.1186/s13020-022-00575-x.

References

Karmeli F, Eliakim R, Okon E, Rachmilewitz D . Ketotifen and nitroxides decrease capsaicin-augmented ethanol-induced gastric damage in rats. Dig Dis Sci. 1995; 40(5):1140-6. DOI: 10.1007/BF02064212. View

Choi C, Cha Y, An C, Kim K, Kim K, Moon S . Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein. Cancer Cell Int. 2004; 4(1):6. PMC: 533863. DOI: 10.1186/1475-2867-4-6. View

Kinoshita M, Noto T, Tamaki H . Effect of a combination of ecabet sodium and cimetidine on experimentally induced gastric lesions and gastric mucosal resistance to ulcerogenic agents in rats. Biol Pharm Bull. 1995; 18(2):223-6. DOI: 10.1248/bpb.18.223. View

Wallace J, Granger D . Pathogenesis of NSAID gastropathy: are neutrophils the culprits?. Trends Pharmacol Sci. 1992; 13(4):129-31. DOI: 10.1016/0165-6147(92)90046-9. View

Sarosiek J, Bilski J, MURTY V, Slomiany A, Slomiany B . Colloidal bismuth subcitrate (De-Nol) inhibits degradation of gastric mucus by Campylobacter pylori protease. Am J Gastroenterol. 1989; 84(5):506-10. View

Kusters J, Van Vliet A, Kuipers E . Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19(3):449-90. PMC: 1539101. DOI: 10.1128/CMR.00054-05. View

Kasuya Y, Urushidani T, Okabe S . Effects of various drugs and vagotomy on indomethacin-induced gastric ulcers in the rat. Jpn J Pharmacol. 1979; 29(4):670-3. DOI: 10.1254/jjp.29.670. View

Leunk R, Johnson P, David B, Kraft W, Morgan D . Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J Med Microbiol. 1988; 26(2):93-9. DOI: 10.1099/00222615-26-2-93. View

Tarnawski A, Tanoue K, Santos A, Sarfeh I . Cellular and molecular mechanisms of gastric ulcer healing. Is the quality of mucosal scar affected by treatment?. Scand J Gastroenterol Suppl. 1995; 210:9-14. DOI: 10.3109/00365529509090261. View

10.

Mizui T, Doteuchi M . Effect of polyamines on acidified ethanol-induced gastric lesions in rats. Jpn J Pharmacol. 1983; 33(5):939-45. DOI: 10.1254/jjp.33.939. View

11.

Tarnawski A, Hollander D, Gergely H, Stachura J . Comparison of antacid, sucralfate, cimetidine, and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med. 1985; 79(2C):19-23. DOI: 10.1016/0002-9343(85)90567-4. View

12.

Veldhuyzen van Zanten S, Sherman P . Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ. 1994; 150(2):177-85. PMC: 1486230. View

13.

Ashley S, Sonnenschein L, Cheung L . Focal gastric mucosal blood flow at the site of aspirin-induced ulceration. Am J Surg. 1985; 149(1):53-9. DOI: 10.1016/s0002-9610(85)80009-x. View

14.

Kahraman A, Erkasap N, Koken T, Serteser M, Aktepe F, Erkasap S . The antioxidative and antihistaminic properties of quercetin in ethanol-induced gastric lesions. Toxicology. 2002; 183(1-3):133-42. DOI: 10.1016/s0300-483x(02)00514-0. View

15.

Arend A, Loime L, Roosaar P, Soom M, Loivukene K, Sepp E . Helicobacter pylori substantially increases oxidative stress in indomethacin-exposed rat gastric mucosa. Medicina (Kaunas). 2005; 41(4):343-7. View

16.

Leirisalo-Repo M, Paimela L, Koskimies S, Repo H . Functions of polymorphonuclear leukocytes in early rheumatoid arthritis. Inflammation. 1993; 17(4):427-42. DOI: 10.1007/BF00916583. View

17.

Seiki M, Ueki S, Tanaka Y, Soeda M, Hori Y, Aita H . [Studies on anti-ulcer effects of a new compound, zinc L-carnosine (Z-103)]. Nihon Yakurigaku Zasshi. 1990; 95(5):257-69. DOI: 10.1254/fpj.95.5_257. View

18.

Tachikawa M, Hosoya K . Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders. Fluids Barriers CNS. 2011; 8(1):13. PMC: 3058069. DOI: 10.1186/2045-8118-8-13. View

19.

Correa P . Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992; 52(24):6735-40. View

20.

Schepers E, Glorieux G, Dou L, Cerini C, Gayrard N, Louvet L . Guanidino compounds as cause of cardiovascular damage in chronic kidney disease: an in vitro evaluation. Blood Purif. 2010; 30(4):277-87. DOI: 10.1159/000320765. View